Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary Syndrome

NCT01581814 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

99

Enrollment

OTHER

Sponsor class

Conditions

Polycystic Ovary Syndrome

Interventions

DRUG: Metformin
DRUG: Yasmin;
DRUG: Metformin plus Yasmin

Sponsor

Catholic University of the Sacred Heart